<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Intanri Kurniati</style></author><author><style face="normal" font="default" size="100%">Agustyas Tjiptaningrum</style></author><author><style face="normal" font="default" size="100%">Raja Iqbal Mulya Harahap</style></author><author><style face="normal" font="default" size="100%">Bayu Putra Danan Jaya</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Serum Trace Element Levels in Type 2 DM Patients and its Correlation with Glycemic Control</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Fasting blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">glycemic control</style></keyword><keyword><style  face="normal" font="default" size="100%">HbA1c</style></keyword><keyword><style  face="normal" font="default" size="100%">trace element serum</style></keyword><keyword><style  face="normal" font="default" size="100%">Type 2 diabetes mellitus</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">660-663</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Type 2 diabetes mellitus, a chronic metabolic disorder, is known to impact serum trace element levels. Objectives: to investigates the association between serum trace elements (Co, Cr, and Cu) and glycemic control in individuals with type 2 diabetes. &lt;strong&gt;Material and Methods:&lt;/strong&gt; A 209 type 2 diabetes patients from Dr. H. Abdul Moeloek Hospital in Bandar Lampung and Hasan Sadikin Hospital in Bandung participated in the study. Patients underwent assessments for serum trace element levels (Co, Cr, and Cu) and glycemic control indicators (FBG and HbA1c). &lt;strong&gt;Results:&lt;/strong&gt; Results indicated significantly lower Co levels in uncontrolled diabetes versus controlled cases (P&amp;lt;0.05). Co, Cr, and Cu levels displayed a significant negative correlation with HbA1c (P&amp;lt;0.05), while Cr and Cu showed a significant negative correlation with FBG (P&amp;lt;0.05). Age did not show significant correlations with serum trace element levels. &lt;strong&gt;Conclusion:&lt;/strong&gt; serum trace element levels (Co, Cr, Cu) are inversely linked to glycemic control in type 2 diabetes individuals.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">660</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Intanri Kurniati&lt;sup&gt;1&lt;/sup&gt;*, Agustyas Tjiptaningrum&lt;sup&gt;1&lt;/sup&gt;, Raja Iqbal Mulya Harahap&lt;sup&gt;2&lt;/sup&gt;, Bayu Putra Danan Jaya&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Clinical Pathology, Faculty of Medicine, Universitas Lampung, Bandar Lampung, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Clinical Pathology, Faculty of Medicine, Universitas Padjajaran – Hasan Sadikin Hospital, Bandung, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Histology and Pathology Laboratory, Faculty of Medicine, Universitas Lampung, Bandar Lampung, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zahra Fadhilah</style></author><author><style face="normal" font="default" size="100%">Berna Elya</style></author><author><style face="normal" font="default" size="100%">Heri Setiawan</style></author><author><style face="normal" font="default" size="100%">Gumilar Adhi Nugroho</style></author><author><style face="normal" font="default" size="100%">Febrika Wediasari</style></author><author><style face="normal" font="default" size="100%">Eem Masaenah</style></author><author><style face="normal" font="default" size="100%">Varda Arianti</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antidiabetic Activity and Phytochemical Constituents of Syzygium cumini Leave in Kadipaten, Central Java Indonesia, Indonesia</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-hyperglicemic</style></keyword><keyword><style  face="normal" font="default" size="100%">Fasting blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">Syzigium cumini</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">1502-1508</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Ethnomedicaly, jamblang (java plum) has been used as antidiabetic treatment in Dayak Tribe. This study aims to evaluate the effectiveness and the safety of the jamblang leaf extract as an antidiabetic. &lt;strong&gt;Objective: &lt;/strong&gt;Evaluate Effecticity of &lt;em&gt;Syzigium cumini&lt;/em&gt; (java plum) as anti-diabetic herb. &lt;strong&gt;Method&lt;/strong&gt;: The antidiabetic activity test, used an animal model which gaven food a high fat diet High Fat Diet (HFD) then it was induced with Streptozotocin injected intraperitoneally. The subjects used in the study were male rats (&lt;em&gt;Ratus novergicus&lt;/em&gt;) Sprague-Dawley strain. &lt;strong&gt;Results:&lt;/strong&gt; Oral administration of jamblang extract has anti hyperglycemic activity through decrease of fasting blood glucose point significantly (dose 1, 50mg/ Kg Bw p: &amp;lt;0.0001, dose 2, 100 mg/Kg BW p: &amp;lt;0.0001).&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1502</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Zahra Fadhilah, Berna Elya*, Heri Setiawan, Gumilar Adhi Nugroho, Febrika Wediasari, Eem Masaenah, Varda Arianti&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;Faculty of Pharmacy, Universitas Indonesia, Depok 16424, West Java, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Welly Ratwita</style></author><author><style face="normal" font="default" size="100%">Elin Yulinah Sukandar</style></author><author><style face="normal" font="default" size="100%">I Ketut Adnyana</style></author><author><style face="normal" font="default" size="100%">Neng Fisheri Kurniati</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Alpha Mangostin and Xanthone Activity on Fasting Blood Glucose, Insulin and Langerhans Islet of Langerhans in Alloxan Induced Diabetic Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Fasting blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">Insulin plasma</style></keyword><keyword><style  face="normal" font="default" size="100%">Langerhans</style></keyword><keyword><style  face="normal" font="default" size="100%">Xanthone</style></keyword><keyword><style  face="normal" font="default" size="100%">α-mangostin</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2019</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2019</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">11</style></volume><pages><style face="normal" font="default" size="100%">64-68</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Objective:&lt;/strong&gt; This research elaborated role of alpha mangostin and xanthone on fasting blood glucose, insulin and langerhans islet in alloxan induced diabetic mice. &lt;strong&gt;Methods:&lt;/strong&gt; Fasting blood glucose, insulin and langerhans islet test were conducted using male &lt;em&gt;Mus musculus&lt;/em&gt; mice, divided into 10 groups randomly, which were normal, control (alloxan induced only), glibenclamide, various doses of α-mangostin and xanthone (5, 10, 20 mg/kgbw). Mice were treated for 21 days. Overnight-fasted mice (12 h) were sacrificed by cervical decapitation on day 21st, following the ethical norms granted by the ethics committee. Fasting blood glucose and insulin plasma were checked. Pancreatic tissues were excised from sacrificed animals, and then fixed in 10 % (v/v) neutral buffered formalin. Histologic observations for Langerhans area were performed after staining using Gomori staining method. &lt;strong&gt;Results:&lt;/strong&gt; The effects of alpha mangostin and xanthone on fasting blood glucose different significantly to control, and were not significantly different from glibenclamide and metformin. Increasing alpha mangostin/xanthone dose from 5 mg/kgbw to 20 mg/bw also did not cause significant differences, although the best results were obtained at a dose of 20 mg/kgbw. Insulin plasma analize showed that there were no significant difference between alpha mangostin/xanthone to normal group, except xanthone 10 mg/kgbw. Langerhans area showed significant difference between alpha mangostin/xanthone to control group. But there’s still had significant difference if we compare to glibenclamid/metformin group.&lt;strong&gt; Conclusion:&lt;/strong&gt; Alpha mangostin and xanthone are two substances that showed antidiabetic effect on fasting blood glucose level, insulin plasma and Langerhans islet.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">64</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Welly Ratwita&lt;sup&gt;*,1&lt;/sup&gt;,&amp;nbsp;Elin Yulinah Sukandar&lt;sup&gt;2&lt;/sup&gt; I Ketut Adnyana&lt;sup&gt;2&lt;/sup&gt; Neng Fisheri Kurniati&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Jenderal Achmad Yani University-Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Bandung Institute of Technology, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Departement of Pharmacology and Clinical Pharmacy, Bandung Institute of Technology, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ampa Konsue</style></author><author><style face="normal" font="default" size="100%">Chusri Talubmook</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Thai Folklore Recipe from Abutilon indicum and Mimosa pudica in Streptozotocin-Induced Diabetic Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">A. indicum</style></keyword><keyword><style  face="normal" font="default" size="100%">Fasting blood glucose</style></keyword><keyword><style  face="normal" font="default" size="100%">M. pudica</style></keyword><keyword><style  face="normal" font="default" size="100%">Thai folklore recipe</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/512</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">480-485</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Context:&lt;/strong&gt; &lt;em&gt;Abutilon indicum&lt;/em&gt; and &lt;em&gt;Mimosa pudica&lt;/em&gt; were a folklore recipe in Northeastern of Thailand. The recipe was reported that claim to diabetic treatment. &lt;strong&gt;Aims:&lt;/strong&gt; The studies were evaluated to hypoglycemic effect, serum insulin secretion and blood biochemistry in streptozotocin (STZ)-induced diabetic rats. &lt;strong&gt;Materials and Methods:&lt;/strong&gt; The recipe were composed of whole plants from &lt;em&gt;A. indicum&lt;/em&gt; and &lt;em&gt;M. Pudica&lt;/em&gt; (1:1 w/w) powder. The pound plants were macerated with aqueous (AMA), hydro-ethanol (AMHE) and 80% ethanol (AME) to crude extracts. The AMA, AMHE and AME at the doses of 125, 250 and 500 mg/kg body weight (b.w.) were administered orally daily in diabetic rats during eight weeks. Fasting blood glucose levels (FBG) were measured at weekly. The serum insulin levels and blood biochemical data including blood urea nitrogen (BUN), creatinine (CREA), total protein (TP), albumin (Alb), serum aspartate aminotransferase (AST), serum alanine aminotransferase (ALT), alkaline phosphatase (ALP), triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL) and low-density lipoprotein (LDL) were estimated at the end of experiment. &lt;strong&gt;Results:&lt;/strong&gt; All doses of the extracts were showed significantly (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.05) decreasing percent age of FBG in diabetic rats. Especially, AME 125 mg/ kg b.w. was showed more potent significantly (&lt;em&gt;p&lt;/em&gt;&amp;lt;0.05) decreasing percentage of FBG at week of 2, 5, 7 and 8. The serum insulin levels of all doses administered with the extracts were significantly (&lt;em&gt;p&lt;/em&gt;&amp;lt; 0.05) higher than diabetic control group. On the other hand, all doses of the extracts were significantly (&lt;em&gt;p&lt;/em&gt;&amp;lt; 0.05) decreasing ALT and ALP lower than diabetic control group. While, AMA and AMHE at the doses of 250 and 500 mg/kg b.w. were increased HDL, but decreased TC, TG and LDL. &lt;strong&gt;Conclusion:&lt;/strong&gt; The study was proved to diabetic treatment and improvement of diabetic stage and blood biochemical parameters. In addition, the experiment was confirmed to folklore traditional use.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">480</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Ampa Konsue&lt;sup&gt;1*&lt;/sup&gt;, Chusri Talubmook&lt;sup&gt;2 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Faculty of Medicine, Mahasarakham University, Maha Sarakham, THAILAND.&lt;/p&gt;
&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biology, Faculty of Sciences, Mahasarakham University, Maha Sarakham, THAILAND.&lt;/p&gt;</style></auth-address></record></records></xml>